Product commercialization case study

A global pharma company needed pharmacovigilance expertise following a European Medicines Agency inspection which resulted in several critical findings. They required a robust pharmacovigilance system that is compliant with the requirements of the FDA, EMA, and other national health authorities. Qinecsa implemented a fully compliant pharmacovigilance framework in line with US, Canadian, and European regulatory […]

Join Qinecsa at WDSC Americas, 4-5 October 2022, Boston

The World Drug Safety Congress Americas brings together over 1000 top leaders and stakeholders in biopharma to discuss the key challenges they are facing in pharmacovigilance and device safety. This year’s agenda will explore strategies in data management & signal detection, showcase how AI & machine learning have improved PV processes, discuss the challenges creating […]

Join Qinecsa at WDSC EU, 27-29 September 2022, Amsterdam

The World Drug Safety Congress Europe brings together over 700 key thought leaders to explore the top challenges within pharmacovigilance. This year’s agenda will explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches, and discuss how to tackle the challenges of social media and drug safety legislation […]

Drug Safety and Pharmacovigilance Services Solutions (DSS) rebrand as Qinecsa Solutions

Patient safety is at the forefront of pharmacovigilance. In a demanding and constantly evolving field, life science companies need expert partners with the right people, processes, and technologies, to generate vital safety insights, rapidly.A trusted partner to global life science companies, Qinecsa brings together best-in-class technology and scientific expertise to connect life science companies to […]